Urticaria as a Cutaneous Manifestation of SARS-CoV-2 Infection - A Case Report
DOI:
https://doi.org/10.66344/jpad.35.2.2025.2413Abstract
The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) virus is responsible for causing the infection known as Coronavirus disease 2019 (COVID-19). Clinical manifestations of COVID-19 have been associated with various symptoms, but skin manifestations are rarely seen. A 25-year-old woman presented with complaints of erythematous urticarial plaques accompanied by itching over buttocks, waist, right arm, and right toe for one day, and confirmed positive for COVID-19. There is research on the timing of skin rash appearance in COVID-19 patients, with 46.1% of rashes appearing simultaneously with prodromal symptoms, 44.3% appearing after and 9.6% appearing before prodromal symptoms, with varying resolution time period.References
World Health Organization. Situation report, 3: Novel Coronavirus (2019-nCoV) outbreak. 2020 [cited 2025 Jun 24]. Available from:
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200123-sitrep-3-2019-ncov.pdf?sfvrsn=d6d23643_8
Lu H, Stratton CW, Tang YW. Outbreak of pneu-monia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4): 401–2.
Dewi MR. Manifestasi Kulit pada Pasien COVID-19. Medula. 2020;10(3):437–42.
Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med. 2020;38(9):1715–21.
Recalcati S. Cutaneous manifestations in COVID?19: a first perspective. J Eur Acad Dermatol Vene-reol. 2020;34(5):e212–3.
Daneshgaran G, Dubin DP, Gould DJ. Cutaneous manifestations of COVID-19: an evidence-based review. Am J Clin Dermatol. 2020;21(5):627–39.
Fernandez?Nieto D, Jimenez?Cauhe J, Suarez?Valle A, Moreno?Arrones OM, Saceda?Corralo D, Arana?Raja A, et al. Comment on: Cutaneous manifestat-ions in COVID?19: a first perspective. Safety con-cerns of clinical images and skin biopsies. J Eur Acad Dermatol Venereol. 2020;34(6):e252–4.
Galvan Casas C, Catala A, Carretero Hernandez G, Rodriguez-Jimenez P, Fernandez-Nieto D, Rodri-guez-Villa Lario A, et al. Classification of the cuta-neous manifestations of COVID?19: a rapid pros-pective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71–7.
Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, et al. Angiotensin?convert-ing enzyme 2 (ACE2), SARS?CoV?2 and the patho-physiology of coronavirus disease 2019 (COVID?19). J Pathol. 2020;251(3):228–48.
Cordoro KM, Reynolds SD, Wattier R, McCalmont TH. Clustered cases of acral perniosis: clinical fea-tures, histopathology, and relationship to COVID?19. Pediatr Dermatol. 2020;37(3):419–23.
Sanchez-Borges M, Asero R, Ansotegui IJ, Baiardini I, Bernstein JA, Canonica GW, et al. Diagnosis and treatment of urticaria and angioedema: a world-wide perspective. World Allergy Organ J. 2012; 5(11):125–47.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
